Création et validation d’un outil de détection de la fraude par falsification d’ordonnance à partir des bases de données de l’Assurance Maladie

Therapies - Tập 64 - Trang 27-31 - 2009
Caroline Victorri-Vigneau1, Katia Larour1, Dominique Simon2, Jacques Pivette2, Pascale Jolliet1
1Service de Pharmacologie Clinique, CEIP, CHU Nantes, France
2Service Médical de l’Assurance Maladie, Nantes, France

Tài liệu tham khảo

Gatignol, 2000, Dispositif d’évaluation de la pharmacodépendance en France, Le courrier des addictions, 1, 25 Baumevieille, 2001, The French system of evaluation of dependence: establishment in a legal system, Therapie, 56, 15 1996, DSM-IV Baumevieille, 1997, Abuse of prescription medicines in southwestern France, Ann Pharmacother, 31, 847, 10.1177/106002809703100706 Lapeyre-Mestre, 1997, Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Community pharmacists of the Midi-Pyrenees, Eur J Clin Pharmacol, 52, 37, 10.1007/s002280050246 Llau, 2002, Forged medical prescriptions in a community pharmacy network in Midi-Pyrenees area: assessment of a falsification ratio, Eur J Clin Pharmacol, 57, 911, 10.1007/s00228-001-0412-7 Thirion, 2002, Buprenorphine prescription by general practitioners in a French region, Drug Alcohol Depend, 65, 197, 10.1016/S0376-8716(01)00161-2 Victorri-Vigneau, 2003, Impacts of the new flunitrazepam regulations on the consumption of hypnotics, Therapie, 58, 425, 10.2515/therapie:2003069 Victorri-Vigneau, 2006, How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France, Eur J Clin Pharmacol, 62, 311, 10.1007/s00228-006-0099-x Frauger, 2003, Misuse of trihexyphenidyl (Artane, Parkinane): recent trends, Therapie, 58, 541, 10.2515/therapie:2003088 Micallef, 2004, Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects, Therapie, 59, 581, 10.2515/therapie:2004100